118 related articles for article (PubMed ID: 8263156)
1. Effect of the serotonin-4 receptor agonist zacopride on aldosterone secretion from the human adrenal cortex: in vivo and in vitro studies.
Lefebvre H; Contesse V; Delarue C; Soubrane C; Legrand A; Kuhn JM; Wolf LM; Vaudry H
J Clin Endocrinol Metab; 1993 Dec; 77(6):1662-6. PubMed ID: 8263156
[TBL] [Abstract][Full Text] [Related]
2. Benzamide derivatives provide evidence for the involvement of a 5-HT4 receptor type in the mechanism of action of serotonin in frog adrenocortical cells.
Idres S; Delarue C; Lefebvre H; Vaudry H
Brain Res Mol Brain Res; 1991 Jun; 10(3):251-8. PubMed ID: 1653392
[TBL] [Abstract][Full Text] [Related]
3. Activation of 5-hydroxytryptamine4 receptors causes calcium influx in adrenocortical cells: involvement of calcium in 5-hydroxytryptamine-induced steroid secretion.
Contesse V; Hamel C; Lefebvre H; Dumuis A; Vaudry H; Delarue C
Mol Pharmacol; 1996 Mar; 49(3):481-93. PubMed ID: 8643088
[TBL] [Abstract][Full Text] [Related]
4. Effect of a series of 5-HT4 receptor agonists and antagonists on steroid secretion by the adrenal gland in vitro.
Contesse V; Hamel C; Delarue C; Lefebvre H; Vaudry H
Eur J Pharmacol; 1994 Nov; 265(1-2):27-33. PubMed ID: 7883026
[TBL] [Abstract][Full Text] [Related]
5. Lack of effect of the serotonin4 receptor agonist zacopride on ACTH secretion in normal men.
Lefebvre H; Contesse V; Delarue C; Kuhn JM; Vaudry H; Wolf LM
Eur J Clin Pharmacol; 1996; 51(1):49-51. PubMed ID: 8880051
[TBL] [Abstract][Full Text] [Related]
6. Serotonin-induced stimulation of cortisol secretion from human adrenocortical tissue is mediated through activation of a serotonin4 receptor subtype.
Lefebvre H; Contesse V; Delarue C; Feuilloley M; Hery F; Grise P; Raynaud G; Verhofstad AA; Wolf LM; Vaudry H
Neuroscience; 1992; 47(4):999-1007. PubMed ID: 1374544
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the 5-HT3 receptor antagonist properties of ICS 205-930, GR38032F and zacopride.
Cohen ML; Bloomquist W; Gidda JS; Lacefield W
J Pharmacol Exp Ther; 1989 Jan; 248(1):197-201. PubMed ID: 2521513
[TBL] [Abstract][Full Text] [Related]
8. Differential modulation of extracellular levels of 5-hydroxytryptamine in the rat frontal cortex by (R)- and (S)-zacopride.
Barnes NM; Cheng CH; Costall B; Ge J; Naylor RJ
Br J Pharmacol; 1992 Sep; 107(1):233-9. PubMed ID: 1384906
[TBL] [Abstract][Full Text] [Related]
9. Characterization of serotonin(4) receptors in adrenocortical aldosterone-producing adenomas: in vivo and in vitro studies.
Lefebvre H; Cartier D; Duparc C; Lihrmann I; Contesse V; Delarue C; Godin M; Fischmeister R; Vaudry H; Kuhn JM
J Clin Endocrinol Metab; 2002 Mar; 87(3):1211-6. PubMed ID: 11889190
[TBL] [Abstract][Full Text] [Related]
10. 5-HT3 receptor agonism may be responsible for the emetic effects of zacopride in the ferret.
Middlefell VC; Price TL
Br J Pharmacol; 1991 May; 103(1):1011-2. PubMed ID: 1831684
[TBL] [Abstract][Full Text] [Related]
11. The enantiomers of zacopride: an intra-species comparison of their potencies in functional and anxiolytic models.
Bill DJ; Coleman J; Hallett I; Middlefell VC; Rhodes KF; Fletcher A
Br J Pharmacol; 1995 Jul; 115(5):775-80. PubMed ID: 8548176
[TBL] [Abstract][Full Text] [Related]
12. Repeated corticosterone administration increases excitatory effect of 5-HT4 receptor agonist in the rat hippocampus.
Zahorodna A; Tokarski K; Bijak M
Pol J Pharmacol; 2000; 52(2):107-9. PubMed ID: 10949112
[TBL] [Abstract][Full Text] [Related]
13. The serotonin-4 receptor agonist cisapride and angiotensin-II exert additive effects on aldosterone secretion in normal man.
Lefebvre H; Contesse V; Delarue C; Legrand A; Kuhn JM; Vaudry H; Wolf LM
J Clin Endocrinol Metab; 1995 Feb; 80(2):504-7. PubMed ID: 7852511
[TBL] [Abstract][Full Text] [Related]
14. Zacopride and BRL 24924 induce an increase in EEG-energy in rats.
Boddeke HW; Kalkman HO
Br J Pharmacol; 1990 Oct; 101(2):281-4. PubMed ID: 2257436
[TBL] [Abstract][Full Text] [Related]
15. Agonist effects at putative central 5-HT4 receptors in rat hippocampus by R(+)- and S(-)-zacopride; no evidence for stereo-selectivity.
Boddeke HW; Kalkman HO
Neurosci Lett; 1992 Jan; 134(2):261-3. PubMed ID: 1589153
[TBL] [Abstract][Full Text] [Related]
16. Preliminary evidence for the involvement of the putative 5-HT4 receptor in zacopride- and copper sulphate-induced vomiting in the ferret.
Bhandari P; Andrews PL
Eur J Pharmacol; 1991 Nov; 204(3):273-80. PubMed ID: 1663456
[TBL] [Abstract][Full Text] [Related]
17. R-zacopride, a 5-HT3 antagonist/5-HT4 agonist, reduces sleep apneas in rats.
Carley DW; Depoortere H; Radulovacki M
Pharmacol Biochem Behav; 2001; 69(1-2):283-9. PubMed ID: 11420096
[TBL] [Abstract][Full Text] [Related]
18. Effects of metoclopramide and tropisetron on aldosterone secretion possibly due to agonism and antagonism at the 5-HT4 receptor.
Sommers DK; Snyman JR; van Wyk M
Eur J Clin Pharmacol; 1996; 50(5):371-3. PubMed ID: 8839658
[TBL] [Abstract][Full Text] [Related]
19. Imipramine-induced subsensitivity to the 5-HT4 receptor activation, a possible mediation via an alteration in the postreceptor transduction mechanism involving adenylate cyclase.
Bijak M
Pol J Pharmacol; 1997; 49(5):345-50. PubMed ID: 9566034
[TBL] [Abstract][Full Text] [Related]
20. The interaction of R(+)- and S(-)-zacopride with PCPA to modify rodent aversive behaviour.
Barnes NM; Costall B; Ge J; Kelly ME; Naylor RJ
Eur J Pharmacol; 1992 Jul; 218(1):15-25. PubMed ID: 1356806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
